Patent Issued for Monoclonal Antibody against Necrosis Marker PRDX4 and Use (USPTO 9164096)

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Source:
    Diabetes Week. November 2, 2015, 222